These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
62 related items for PubMed ID: 2795243
21. Antagonism of gastric inhibitory polypeptide (GIP) by palmitoylation of GIP analogues with N- and C-terminal modifications improves obesity and metabolic control in high fat fed mice. Pathak V, Gault VA, Flatt PR, Irwin N. Mol Cell Endocrinol; 2015 Feb 05; 401():120-9. PubMed ID: 25449420 [Abstract] [Full Text] [Related]
22. Regulation of glucose-dependent insulinotropic peptide gene expression by a glucose meal. Tseng CC, Jarboe LA, Wolfe MM. Am J Physiol; 1994 May 05; 266(5 Pt 1):G887-91. PubMed ID: 8203533 [Abstract] [Full Text] [Related]
23. Metabolic clearance rate and secretion rate of gastric inhibitory polypeptide in the rat. Sheu WJ, Pu HF, Wang SW, Ho LL, Wang PS. Chin J Physiol; 1987 May 05; 30(1):25-33. PubMed ID: 3691206 [Abstract] [Full Text] [Related]
24. Blood insulin, glucose, fructose and gastric inhibitory polypeptide levels in carbohydrate-sensitive and normal men given a sucrose or invert sugar tolerance test. Ellwood KC, Michaelis OE, Hallfrisch JG, O'Dorisio TM, Cataland S. J Nutr; 1983 Sep 05; 113(9):1732-6. PubMed ID: 6350543 [Abstract] [Full Text] [Related]
25. Release of glucagon-like peptide-1 (GLP-1) by carbohydrates in the perfused rat ileum. Ritzel U, Fromme A, Ottleben M, Leonhardt U, Ramadori G. Acta Diabetol; 1997 Mar 05; 34(1):18-21. PubMed ID: 9134052 [Abstract] [Full Text] [Related]
26. Gastric inhibitory polypeptide and the entero-insular axis in streptozotocin diabetic mice. Bailey CJ, Flatt PR, Kwasowski P, Adams M. Diabete Metab; 1986 Dec 05; 12(6):351-4. PubMed ID: 3545933 [Abstract] [Full Text] [Related]
27. Increased plasma response of gastric inhibitory polypeptide to oral glucose and a liquid meal after prolonged starvation in healthy man. Oektedalen O, Opstad PK, Jorde R. Digestion; 1983 Dec 05; 26(3):114-23. PubMed ID: 6343163 [Abstract] [Full Text] [Related]
29. A comparison of the cellular and biological properties of DPP-IV-resistant N-glucitol analogues of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide. Green BD, Gault VA, O'Harte FP, Flatt PR. Diabetes Obes Metab; 2005 Sep 05; 7(5):595-604. PubMed ID: 16050953 [Abstract] [Full Text] [Related]
30. The effect of gastric inhibitory polypeptide on intestinal glucose absorption and intestinal motility in mice. Ogawa E, Hosokawa M, Harada N, Yamane S, Hamasaki A, Toyoda K, Fujimoto S, Fujita Y, Fukuda K, Tsukiyama K, Yamada Y, Seino Y, Inagaki N. Biochem Biophys Res Commun; 2011 Jan 07; 404(1):115-20. PubMed ID: 21095180 [Abstract] [Full Text] [Related]
31. Antidiabetic potential of two novel fatty acid derivatised, N-terminally modified analogues of glucose-dependent insulinotropic polypeptide (GIP): N-AcGIP(LysPAL16) and N-AcGIP(LysPAL37). Irwin N, Gault VA, Green BD, Greer B, Harriott P, Bailey CJ, Flatt PR, O'Harte FP. Biol Chem; 2005 Jul 07; 386(7):679-87. PubMed ID: 16207089 [Abstract] [Full Text] [Related]
33. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations. Nauck MA, Bartels E, Orskov C, Ebert R, Creutzfeldt W. J Clin Endocrinol Metab; 1993 Apr 07; 76(4):912-7. PubMed ID: 8473405 [Abstract] [Full Text] [Related]
34. Administration of an acylated GLP-1 and GIP preparation provides added beneficial glucose-lowering and insulinotropic actions over single incretins in mice with Type 2 diabetes and obesity. Gault VA, Kerr BD, Harriott P, Flatt PR. Clin Sci (Lond); 2011 Aug 07; 121(3):107-17. PubMed ID: 21332446 [Abstract] [Full Text] [Related]
35. Insulin modulates glucose-dependent insulinotropic polypeptide (GIP) secretion from enteroendocrine K cells in rats. Irwin N, Francis JM, Flatt PR. Biol Chem; 2011 Oct 07; 392(10):909-18. PubMed ID: 21851286 [Abstract] [Full Text] [Related]
36. Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. Stock S, Leichner P, Wong AC, Ghatei MA, Kieffer TJ, Bloom SR, Chanoine JP. J Clin Endocrinol Metab; 2005 Apr 07; 90(4):2161-8. PubMed ID: 15657373 [Abstract] [Full Text] [Related]
37. Carbohydrate-induced secretion of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1. Seino Y, Maekawa R, Ogata H, Hayashi Y. J Diabetes Investig; 2016 Apr 07; 7 Suppl 1(Suppl 1):27-32. PubMed ID: 27186352 [Abstract] [Full Text] [Related]
38. Gastric inhibitory polypeptide responses and glucose turnover rates after natural meals in type II diabetic patients. Osei K, Falko JM, O'Dorisio TM, Fields PG, Bossetti B. J Clin Endocrinol Metab; 1986 Feb 07; 62(2):325-30. PubMed ID: 3510224 [Abstract] [Full Text] [Related]
39. Relationship between molecular structures of sugars and their ability to stimulate the release of glucagon-like peptide-1 from canine ileal loops. Shima K, Suda T, Nishimoto K, Yoshimoto S. Acta Endocrinol (Copenh); 1990 Oct 07; 123(4):464-70. PubMed ID: 2239092 [Abstract] [Full Text] [Related]